The pharmaceutical industry continues to transform as scientific discovery, digital integration, and healthcare policy reforms reshape global treatment landscapes. Within this evolving framework, the Antimetabolite Drugs Market maintains a critical presence in oncology and immunology care. These therapies, long established for their role in inhibit